Strategic Partnerships BioConnection partners with emerging biopharma players and has recent collaboration news with Infant Bacterial Therapeutics AB, signaling openness to Drug Product manufacturing partnerships and joint development opportunities that could expand the addressable market for cGMP injectable production and PPQ-ready materials.

Scale and Flex With capabilities from clinical material to market production up to 500 L and special small-scale hand fill for personalized medicines, BioConnection offers a scalable, flexible CMO solution suitable for pilot programs, niche therapies, and Phase I-III projects—a strong fit for sponsors seeking rapid scale-up within controlled timelines.

Quality and Compliance FDA and EMA-certified facility plus comprehensive CMC services position BioConnection as a reliable partner for high-quality injectable biologics and small molecules, appealing to sponsors prioritizing regulatory readiness, seamless tech transfers, and efficient PPQ campaigns to shorten time-to-market.

Industry Recognition Recent awards and board-level hires, including European CMO of the Year and European Company of the Year recognitions, alongside strategic leadership additions, enhance credibility with potential clients and can be leveraged in outreach to win larger, multi-year manufacturing programs.

Growth Signals Revenue scale and notable partnerships with industry players, plus a growing leadership team, indicate an expanding commercial footprint and potential cross-sell opportunities across CMC services from drug product development through fill and finish, offering multi-faceted value to biotech and pharma customers.